AldexChem is a solution and platform provider for the Chemical and Life Science industries. Our mission is to support the development of new therapies that will improve the lives of millions worldwide.
AldexChem developed a novel hydrosilylation reaction filing its primary IP as SilBoRed™. A technology to reduce esters to aldehydes which are difficult, if not impossible with the standard chemistry toolbox. SilBoRed™ technology opened up a novel chemical space, leading to several industrial applications.
We are dedicated to provide robust and scalable tools for the chemical industries and we develop building blocks for a wide range of applications.
One of these applications is creating novel ionizable cationic lipid families, which belong to the trademark LipexSil™ and filing AldexChem's secondary IP. LipexSil™ lipid families are a solution to one of the most pressing challenges of the pharma industry – the delivery of biologically active agents.
LipexSil™ novel ionizable lipids can be used in the preparation of LNPs to facilitate the therapeutic oligonucleotides into cells.
We strive to solve challenges faced by the pharma industry, such as efficient delivery of biologically active agents with the help of our SilBoRed™ and LipexSil™ technologies. Our vision is to inspire change in the scientific community by pushing the boundaries of chemical synthesis. We think that by empowering the Chemical and Life Science sector with innovative and impactful solutions, we can contribute to a brighter future for all.
József, a dedicated entrepreneur and veteran of the Life Science Industry, started his last company, a custom development and manufacturing organisation in 1996. By January 2021 the company reached EUR 25 million annual revenue and József sold his share and started his new venture, AldexChem as Founder and Managing Director.
Markus, a veteran ofLife Science Industry, has 25 years experience in research and development of novel and proprietary therapeutics. Markus was Head of Drug Discovery and Development of a German pharma company and he left the company in 2014 to start his consulting business for the Life Science Industry.
Get in touch with us.